Do breast cancer drugs cloud your mind? study compares memory effects
NCT ID NCT00893061
Summary
This study compared how different hormone therapies for breast cancer affect memory and thinking skills. Researchers followed 44 postmenopausal women with early-stage breast cancer for one year, comparing standard tamoxifen treatment against newer aromatase inhibitors. The goal was to understand which treatment might have less impact on cognitive functions like memory, attention, and problem-solving.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Eugene Marquis
Rennes, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre Paul Strauss
Strasbourg, France
Conditions
Explore the condition pages connected to this study.